Nisa Investment Advisors
LENZ icon

Nisa Investment Advisors’s LENZ Therapeutics LENZ Stock Holding History

Nisa Investment Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.8K Buy
9,300
+9,281
+48,847% +$74.8K ﹤0.01% 1833
2026
Q1 		$174 Buy
+19
New +$267 ﹤0.01% 2994
2025
Q4 		– Sell
-244
Closed -$11.4K – 3109
2025
Q3 		$11.4K Hold
244
– – ﹤0.01% 2229
2025
Q2 		$7.15K Buy
244
+211
+639% +$5.74K ﹤0.01% 2382
2025
Q1 		$848 Sell
33
-1
-3% -$25 ﹤0.01% 2677
2024
Q4 		$982 Buy
34
+12
+55% +$366 ﹤0.01% 2691
2024
Q3 		$522 Buy
+22
New +$488 ﹤0.01% 2717
2024
Q2 		– Sell
-644
Closed -$14.4K – 2983
2024
Q1 		$14.4K Hold
644
– – ﹤0.01% 1970
2023
Q4 		$11.8K Buy
644
+28
+5% +$462 ﹤0.01% 2005
2023
Q3 		$10.7K Buy
+616
New +$10.7K ﹤0.01% 2161

Other funds holding LENZ

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Nisa Investment Advisors's LENZ Position: Q2 2026 in Review

Nisa Investment Advisors increased its LENZ Therapeutics (LENZ) stake by 48,847% in Q2 2026, buying an estimated $74.8K and bringing the position to 9,300 shares worth $52.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Nisa Investment Advisors first reported a position in LENZ in Q3 2023 and has held it in 10 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Nisa Investment Advisors held 9,300 shares of LENZ Therapeutics worth $52.8K as of Q2 2026.
  • Nisa Investment Advisors bought 9,281 LENZ Therapeutics shares in Q2 2026, an estimated $74.8K.
  • LENZ Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1833 holding.
  • Nisa Investment Advisors first reported a position in LENZ Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.